Skip to Main Content

Jeanmarie Perrone

Contact Information

Jeanmarie Perrone

Biography

Jeanmarie Perrone, MD (at UPENN) founding director of the Penn Medicine Center for Addiction Medicine and Policy and is board certified in emergency medicine, medical toxicology, and addiction medicine.

Her area of expertise is unique in this group as a medical toxicologist focusing on ED poisonings and overdoses 163-165 recognizing the emerging opioid crisis in the first decade of 2000 and now using more sophisticated methods of natural language processing and machine learning to develop toxicosurveillance strategies to “listen” to social media chatter about emerging drug use such as xylazine and fentanyl.166-171

Additionally, she has partnered with former mentees at Brown 172-173 to interpret forensic analysis of SUDORS (State Unintentional Drug Overdose Reporting System) data with respect to opioid overdoses and buprenorphine.

She leads health system implementation efforts at UPenn to enhance clinician education and identification of opioid use disorder and buprenorphine initiation and naloxone dispensing from the emergency department (ED).174-177 She also directs the OUTREACH (Organizing the Use and Training of Recovery Experts to Add to Community Health) program at Penn, which seeks to disseminate best practices for training, implementing, and supporting peer recovery specialists in ED settings.

She is currently the site PI and Core Co-I in a NIDA ED INNOVATION study (CTN 0099). She is also the PI of a SAMSHA funded TEACH-UP (Teaching Excellence in Addiction Care at the Hospitals of the University of Pennsylvania) developing training expertise and readiness to administer and prescribe buprenorphine.

In addition, she serves as Co-I on two CDC-funded studies:

  1. to leverage tools in the electronic health records to increase identification and treatment of patients with OUD in the ED
  2. to assess the implementation and effectiveness of alternative responses to overdose and environmental mitigation to follow changes in overdoses rates in areas that have undergone blight remediation.